C Chard wrote a memo to G Hardy providing evidence that plasma from outside the US and Europe was still being "routinely" used in the production of albumin products at its facility in Lessines, Belgium, that those products were imported to the UK, and that this was in contravention of the product licence that specified the use of US plasma. Read more about C Chard wrote a memo to G Hardy providing evidence that plasma from outside the US and Europe was still being "routinely" used in the production of albumin products at its facility in Lessines, Belgium, that those products were imported to the UK, and that this was in contravention of the product licence that specified the use of US plasma.
Immuno employed a system of "Neutral texts" (wording that could be used in any countries where there was no requirement for a specific formulation, including for unlicensed products in the UK) and "UK specific texts" which had the approval of the UK licensing authority and had to be used for a licensed product. Read more about Immuno employed a system of "Neutral texts" (wording that could be used in any countries where there was no requirement for a specific formulation, including for unlicensed products in the UK) and "UK specific texts" which had the approval of the UK licensing authority and had to be used for a licensed product.
Dr Jones drafted a memo describing the circumstances in which he was invited by Armour to inspect and report on facilities supplying Armour with plasma through its subsidiary company, Plasma Alliance. Read more about Dr Jones drafted a memo describing the circumstances in which he was invited by Armour to inspect and report on facilities supplying Armour with plasma through its subsidiary company, Plasma Alliance.
Dr Thomas Cleghorn stated in an interview that he had been told that from November 1975 only plasma from the mainland US would be used. Read more about Dr Thomas Cleghorn stated in an interview that he had been told that from November 1975 only plasma from the mainland US would be used.
H L Shaw sent a telex to Kas Egerton contributing to the provisional view that Armour might still, on occasion, be reliant on external purchases, before the definitive answer was received from Dr Rodell of the US parent company: Read more about H L Shaw sent a telex to Kas Egerton contributing to the provisional view that Armour might still, on occasion, be reliant on external purchases, before the definitive answer was received from Dr Rodell of the US parent company:
W Tarbit sent a telex to Dr Rodell suggesting that Armour might still, on occasion, be reliant on external purchases. It seems that this may have been a provisional view expressed by the officers of the UK subsidiary before the definitive answer was received from Dr Rodell of the US parent company. Read more about W Tarbit sent a telex to Dr Rodell suggesting that Armour might still, on occasion, be reliant on external purchases. It seems that this may have been a provisional view expressed by the officers of the UK subsidiary before the definitive answer was received from Dr Rodell of the US parent company.
Dr Michael Rodell sent a telex to W Tarbit which showed that self-sufficiency, at least for Factorate, had been achieved by June 1983. Read more about Dr Michael Rodell sent a telex to W Tarbit which showed that self-sufficiency, at least for Factorate, had been achieved by June 1983.
Armour stated that: "Plasma Alliance's [the plasma collection company affiliated with Armour] 22 centres are responsible for collecting from approximately 22,000 donors registered at any one time." Annually, over one million plasma donations were processed. It follows that a patient receiving a single infusion of Factorate in the later 1970s would be exposed to somewhere in the region of 1,540 donations. Read more about Armour stated that: "Plasma Alliance's [the plasma collection company affiliated with Armour] 22 centres are responsible for collecting from approximately 22,000 donors registered at any one time." Annually, over one million plasma donations were processed. It follows that a patient receiving a single infusion of Factorate in the later 1970s would be exposed to somewhere in the region of 1,540 donations.
Armour published Plasma Perspectives No 1 which referred to Factorate being manufactured from pools of "only approximately 2,000 donors." It is not clear if this is a less precise formulation of the same idea, or whether it reflects an increase in the size of the plasma pools between the mid 1970s and 1981. Read more about Armour published Plasma Perspectives No 1 which referred to Factorate being manufactured from pools of "only approximately 2,000 donors." It is not clear if this is a less precise formulation of the same idea, or whether it reflects an increase in the size of the plasma pools between the mid 1970s and 1981.
In his report of his visit to plasmapheresis centres, Dr Peter Jones commented that: "It is imperative that the Revlon Health Care Group [which owned Armour] became totally self-sufficient in terms of source plasma." Read more about In his report of his visit to plasmapheresis centres, Dr Peter Jones commented that: "It is imperative that the Revlon Health Care Group [which owned Armour] became totally self-sufficient in terms of source plasma."